These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15646358)

  • 1. [Intelligent polymeric systems for glucose-responsive insulin delivery].
    Qu J; Chu L; Li Y; Chen W; Zheng C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):1028-30. PubMed ID: 15646358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug delivery system for diabetes].
    Yamasaki Y
    Nihon Rinsho; 1998 Mar; 56(3):748-51. PubMed ID: 9549368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
    Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
    J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosensing and drug delivery at the microscale : novel devices for controlled and responsive drug delivery.
    Robitzki AA; Kurz R
    Handb Exp Pharmacol; 2010; (197):87-112. PubMed ID: 20217527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research on intelligent controlled drug delivery with polymer].
    Zhang Z; Tang C; Chen H; Shan L; Wan C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):205-8, 224. PubMed ID: 16532842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
    Wu ZH; Ping QN; Wei Y; Lai JM
    Acta Pharmacol Sin; 2004 Jul; 25(7):966-72. PubMed ID: 15210073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
    Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
    J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP.
    Zhao Y; Trewyn BG; Slowing II; Lin VS
    J Am Chem Soc; 2009 Jun; 131(24):8398-400. PubMed ID: 19476380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the stability of insulin delivered through a new glucose-responsive polymeric composite membrane.
    Zhang K; Quan C; Huang H; Taulier N; Wu XY
    J Pharm Pharmacol; 2004 May; 56(5):611-20. PubMed ID: 15142338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary delivery of insulin by liposomal carriers.
    Huang YY; Wang CH
    J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles.
    Jintapattanakit A; Junyaprasert VB; Mao S; Sitterberg J; Bakowsky U; Kissel T
    Int J Pharm; 2007 Sep; 342(1-2):240-9. PubMed ID: 17597316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle strategies for the oral delivery of insulin.
    Damgé C; Reis CP; Maincent P
    Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of the liposomes coated by chitosan and its derivatives on the gastrointestinal transit of insulin].
    Wu ZH; Ping QN; Lei XM; Li JY; Cai P
    Yao Xue Xue Bao; 2005 Jul; 40(7):618-22. PubMed ID: 16196267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current challenges in non-invasive insulin delivery systems: a comparative review.
    Khafagy el-S; Morishita M; Onuki Y; Takayama K
    Adv Drug Deliv Rev; 2007 Dec; 59(15):1521-46. PubMed ID: 17881081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained insulin release with biodegradation of chitosan gel beads prepared by copper ions.
    Kofuji K; Murata Y; Kawashima S
    Int J Pharm; 2005 Oct; 303(1-2):95-103. PubMed ID: 16139972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemically controlled closed-loop insulin delivery.
    Ravaine V; Ancla C; Catargi B
    J Control Release; 2008 Nov; 132(1):2-11. PubMed ID: 18782593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
    Laube BL
    Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
    Packhaeuser CB; Kissel T
    J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered polymers and polymeric systems in controlled drug delivery and targeting. Preface.
    Avgoustakis K
    Eur J Pharm Biopharm; 2009 Mar; 71(3):407-8. PubMed ID: 19150405
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of absorption promoters on insulin absorption through colon-targeted delivery.
    Katsuma M; Watanabe S; Kawai H; Takemura S; Sako K
    Int J Pharm; 2006 Jan; 307(2):156-62. PubMed ID: 16289574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.